Earnings Summary

Newlink Genetics Corporation’s revenue jumped 30.77% since last year same period to $0.53Mn in the Q2 2023. On a quarterly growth basis, Newlink Genetics Corporation has generated -23.73% fall in its revenue since last 3-months.

Newlink Genetics Corporation’s net profit fell -13.86% since last year same period to $-8.93Mn in the Q2 2023. On a quarterly growth basis, Newlink Genetics Corporation has generated -34.16% fall in its net profits since last 3-months.

Newlink Genetics Corporation’s net profit margin jumped 12.93% since last year same period to -1694.69% in the Q2 2023. On a quarterly growth basis, Newlink Genetics Corporation has generated -75.91% fall in its net profit margins since last 3-months.

Newlink Genetics Corporation’s earning per share (EPS) estimates for the current quarter stand at -0.96 - a 4.95% jump from last quarter’s estimates.

Newlink Genetics Corporation’s earning per share (EPS) estimates for the current year stand at -0.96.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Newlink Genetics Corporation’s return on assets (ROA) stands at -0.3.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Newlink Genetics Corporation’s return on equity (ROE) stands at -0.54.